JAMA Network Open: Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022
This cross-sectional study found that increasing telehealth utilization across medications suggests a growing acceptance, need, or preference for remote services. Opioid prescriptions declined before Q2 of 2020 and continued to decrease by 17.2% from 2019 to 2022. In-person visits accounted for most opioid prescriptions, with telehealth prescriptions reaching 24.1% in Q2 of 2020 and leveling off at 8.4% in 2022, an increase from 0% in 2019.
Loading...
Reload document 
Open in new tab